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Abstract
Metastasis Associated in Colon Cancer 1 (MACC1) is a novel prognostic, predictive and causal biomarker for tumor pro-
gression and metastasis in many cancer types, including colorectal cancer. Besides its clinical value, little is known about 
its molecular function. Its similarity to SH3BP4, involved in regulating uptake and recycling of transmembrane receptors, 
suggests a role of MACC1 in endocytosis. By exploring the MACC1 interactome, we identified the clathrin-mediated endo-
cytosis (CME)-associated proteins CLTC, DNM2 and AP-2 as MACC1 binding partners. We unveiled a MACC1-dependent 
routing of internalized transferrin receptor towards recycling. Elevated MACC1 expression caused also the activation and 
internalization of EGFR, a higher rate of receptor recycling, as well as earlier and stronger receptor activation and downstream 
signaling. These effects are limited by deletion of CME-related protein interaction sites in MACC1. Thus, MACC1 regulates 
CME and receptor recycling, causing increased growth factor-mediated downstream signaling and cell proliferation. This 
novel mechanism unveils potential therapeutic intervention points restricting MACC1-driven metastasis.
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MACC1  Metastasis Associated in Colon Cancer 1
CME  Clathrin-mediated endocytosis
CLTC  Clathrin heavy chain 1
DNM  Dynamin
AP  Adaptor protein
EGF  Epidermal growth factor
EGFR  EGF receptor
CRC  Colorectal cancer
SH3  Src homology 3
EPS15  Epidermal growth factor receptor substrate 15
SH3BP4  SH3 binding protein 4
Tf  Transferrin
TfR  Transferrin receptor
RTK  Receptor tyrosine kinase
MS  Mass spectrometry
IP  Immunoprecipitation
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PM  Plasma membrane
CCV  Clathrin-coated vesicle
EEA1  Early endosomal antigen 1
LAMP1  Lysosomal-associated membrane glycoprotein 
1
Erk1/2  Mitogen-activated protein kinase ½
CCND1  Cyclin D1
NOS2  Inducible nitric oxide synthase
COX-2  Cyclooxygenase-2
MYBL2  Myb-related protein B
AURKA  Aurora kinase A
MYC  Myc proto-oncogene protein
BCRP  Breast cancer resistant protein
Introduction
Colorectal cancer (CRC) is the third most common cancer 
type in incidence worldwide, but second in mortality [1]. 
Although progress has been made in understanding this dis-
ease and in the availability of therapeutic interventions [2], 
the mortality of CRC patients remains high. Metastasis for-
mation of CRC is the major cause of treatment failure and 
thus disease-related death [3]. To improve the survival of 
CRC patients, prognostic and causal biomarkers are needed 
to evaluate the risk of metastasis formation. Identifying 
molecular mechanisms of disease-driving factors facilitates 
the search for novel therapeutic intervention points.
A strong prognostic biomarker and metastasis inducer 
is the gene Metastasis Associated in Colon Cancer  1 
(MACC1) [4]. Overexpression of MACC1 leads to progres-
sion and metastasis of many solid tumor entities, by promot-
ing cell proliferation and migration, and thereby enhancing 
tumor growth and invasion [5–7]. The effect of MACC1 on 
promoting cancer progression and metastasis, as well as in 
reduced drug sensitivity has been reported in association 
with several cellular signaling pathways involved in carcino-
genesis [7], but detailed molecular mechanisms of MACC1 
in cancer progression are less well known.
The protein sequence of MACC1 is 43.7% homologous 
to Src homology 3 (SH3) binding protein 4 (SH3BP4) [8]. 
The predicted protein domains and interaction motifs of 
MACC1 and SH3BP4 show overlapping features: an N-ter-
minal clathrin box, interaction motifs for the α-adaptin 
appendage domain of the adaptor protein 2 (AP-2) com-
plex (Asp–Pro–Phe/DPF), the Eps15 homology domain 
(Asn–Pro–Phe/NPF), a central ZU5-/UPA-domain tan-
dem, an SH3-domain and a tandem of death domains [9]. 
SH3BP4 has been reported to regulate the internalization of 
the transferrin receptor (TfR), by interacting with endocytic 
proteins such as clathrin and dynamin [8]. SH3BP4 localizes 
to TfR-containing vesicles and the perturbation of SH3BP4 
expression interferes with the uptake of TfR. It has also been 
shown that SH3BP4 is involved in fibroblast growth factor 
signaling and can regulate the fate of the activated receptor, 
mediating its recycling or degradation, depending on the 
activating ligand and recruitment of SH3BP4 to the cyto-
plasmic tail of the receptor [10].
Considering the homology between MACC1 and 
SH3BP4, and the function of SH3BP4 in regulating endocy-
tosis and receptor signaling in cancer cells, we hypothesize 
a role of MACC1 in clathrin-mediated endocytosis (CME) 
and investigated its effect on iron accumulation and receptor 
tyrosine kinase (RTK) signaling, and thus promoting CRC 
cell proliferation and metastasis.
Materials and methods
Shot‑gun proteomics of MACC1 interactors and data 
analysis
For identification of the MACC1 interactome by MS (shot-
gun proteomics), immunoprecipitation of SW620 cells 
with two polyclonal rabbit anti-human MACC1 antibodies 
(HPA020103, HPA020081, Sigma, St. Louis, USA, 2 µg) 
was performed 4 times independently. Samples were eluted 
from the affinity beads using denaturing buffer (6 M urea, 
2 M thiourea, 20 mM HEPES, pH 8.0, Sigma). Proteins were 
converted to peptides in a two-step digestion using endo-
peptidase LysC (Wako, Japan) and trypsin (Promega, Madi-
son, WI, USA). The peptides were desalted using Stage-Tips 
following a protocol by Rappsilber et al. [11]. The puri-
fied peptides were then resuspended in 3% trifluoroacetic 
acid/5% acetonitrile buffer (Sigma, Merck) and separated 
on a reversed-phase column (20 cm length, 75 μm ID, 3 μm 
Reprosil-C18, Dr. Maisch) with a gradient from 5 to 45% 
acetonitrile in 122 min. Peptides were ionized on a Proxeon 
ion source and directly sprayed into the mass spectrometer 
(Q-Exactive, Thermo Fisher). The recorded spectra were 
analyzed using the MaxQuant software package (Version, 
1.2.2.5) [12] with fixed modifications set to carbamylation of 
cysteines and variable modifications set to phosphorylation 
of serine, threonine, and tyrosine, and methionine oxidation. 
The false-discovery rate was set to 0.1 on protein and peptide 
level. Statistical analysis of the data set was performed using 
the R-statistical software package [13].
Enrichment of functional categories among the identi-
fied proteins was performed using the online tool DAVID 
(v6.7) [14]: proteins were searched against a curated list of 
gene ontology terms that exclude very broad terms based 
on a measured specificity of each term (GO_FAT) and 
otherwise using standard parameters. Resulting functional 
categories were filtered for p values lower than 0.05 and 
Benjamini–Hochberg corrected p values lower than 10%.
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Cloning of MACC1‑GFP deletion constructs
The plasmid RC224774L2 (Origene, Rockville, Maryland) 
was used to create cytomegalovirus (CMV) promoter-driven 
overexpression of human MACC1 (NM_182762) as a C-ter-
minal GFP fusion protein. Parallel deletion of N-terminal 
CME binding sites occurred via Gibson assembly of a syn-
thesized dsDNA fragment (Integrated DNA Technology, 
Leuven, Belgium) spanning 96 nt upstream of the MACC1 
start codon (homologous to the vector sequence), miss-
ing the nucleotides 64–80 (clathrin box), 193–201 (NPF), 
222–230 (NPF) and 295–303 (DPF), and ends at nucleotide 
434 downstream of the MACC1 start codon. The vector was 
gapped with the restriction enzymes SfaAI and BseJI (Fast 
Digest, Thermo Scientific). A region around the previously 
described deletion of the SH3 domain of MACC1 [4] was 
amplified and cloned via Gibson assembly into the target 
vectors, gapped with the restriction enzymes XhoI and 
PshAI (Fast Digest, Thermo Scientific). The exact sequences 
of the synthesized fragment, the primers or the generated 
vectors are available on request.
Cell culture
Human CRC cell lines SW480 and SW620 were obtained 
from American Type Culture Collection (ATCC). Cells 
were grown in RPMI 1640 and DMEM medium (Invitro-
gen, Germany), respectively, supplemented with 10% fetal 
calf serum (FCS; BIO&SELL, Germany) in a fully humidi-
fied incubator at 37 °C with 5%  CO2. All cells were free of 
mycoplasma, confirmed with the MycoAlert mycoplasma 
detection kit (Lonza, US). GFP and MACC1 GFP constructs 
were stably transduced by lentiviral particles and selected 
via FACS, generating SW480/GFP, SW480/MACC1 GFP, 
SW480/MACC1ΔNT GFP, SW480/MACC1ΔSH3 GFP and 
SW480/MACC1ΔNTΔSH3 GFP cells, respectively. SW480/
empty vector (e.v.), SW480/MACC1, SW620/sh control, 
SW620/sh MACC1, HCT116/GFP and HCT116/MACC1 
GFP cells were previously established [6, 15].
Protein extraction and WB
For total protein extraction, cells were lysed with RIPA 
buffer for 30 min on ice. Protein samples of equal amount 
were boiled for 5 min in NuPage (Invitrogen) sample buffer 
supplemented with 10% DTT. Samples were separated by 
SDS-PAGE and transferred onto nitrocellulose membranes 
(GE Healthcare, followed by immunoblotting with the indi-
cated primary and corresponding secondary antibodies (see 
Supplementary Table 1). Chemiluminescence was visual-
ized on Fuji medical X-ray films SuperRX (Fujifilm, Tokyo, 
Japan) using the WesternBright ECL kit (Advansta; Menlo 
Park, CA, USA). For membrane fractionation, cells were 
grown to sub-confluency, starved in serum-free medium for 
1 h, and were treated with 50 µg/ml h-TF for 15 min or 
PBS, respectively. Cells were washed once with PBS and 
subjected to protein extraction from the plasma membrane 
with the Plasma Membrane Protein Extraction Kit (abcam), 
following the manufacturers’ instructions. Detection of TfR 
and Na/K-ATPase was performed via SDS-PAGE and WB.
Immunoprecipitation
Cells were lysed in CoIP lysing buffer (20 mM Tris–HCl pH 
7.5, 150 mM NaCl, 0.1% NP40, 1 mM EDTA, 1% Triton X 
100, supplemented with complete protease inhibitor tablets; 
Roche) for 30 min on ice. Protein lysates were incubated 
over night with 4 µg of target specific antibodies (see Sup-
plementary Table 1) at 4 °C. Antibody/protein complexes 
were captured via protein-G-coupled Sepharose beads (Inv-
itrogen, Darmstadt, Germany) for 2 h at 4 °C. Beads were 
washed in CoIP lysis buffer three times before. Samples 
were incubated at 95 °C for 5 min and subjected to SDS-
PAGE and WB.
RNA extraction and quantitative PCR
Total RNA was isolated from cell cultures with TRIzol rea-
gent (Invitrogen) according to the manufacturer’s instruc-
tions. Complementary DNA was synthesized from 50 ng of 
total RNA with random hexamers in a reaction mix (10 mM 
 MgCl2, 1 × PCR Buffer II, 0.25 µM pooled dNTPs, 1 U 
RNAse inhibitor, 2.5 U Moloney murine leukemia virus 
reverse transcriptase; all from Applied Biosystems). Reac-
tion was performed at 42 °C for 15 min, 99 °C for 5 min, and 
subsequent cooling at 5 °C for 5 min. mRNA expression of 
MACC1, TfR, SH3BP4, EGFR and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was measured by qRT-PCR 
using the GoTaq qPCR Master Mix (Promega, Germany) in 
a LightCycler 480 system (Roche Diagnostics) at the fol-
lowing PCR conditions: 95 °C for 2 min followed by 45 
cycles of 95 °C for 7 s, 60 °C for 10 s and 72 °C for 20 s, 
in duplicates. The primers for MACC1, TfR, SH3BP4 and 
GAPDH were as follows: MACC1 forward, 5′ TTC TTT TGA 
TTC CTC CGG TGA 3′ and reverse, 5′ ACT CTG ATG GGC 
ATG TGC TG 3′; TfR forward, 5′ GGC TAC TTG GGC TAT 
TGT AAAGG 3′ and reverse, 5′ CAG TTT CTC CGA CAA 
CTT TCTCT 3′; SH3BP4 forward, 5′ ACA ACA CCA CCG 
AAA TGG G 3′ and reverse, 5′ ATC ATA CCG CTG TCA CTC 
AGT 3′; EGFR forward 5′ AGG CAC GAG TAA CAA GCT 
CAC 3′ and reverse, 5′ ATG AGG ACA TAA CCA GCC ACC 
3′; GAPDH forward, 5′ GAA GAT GGT GAT GGG ATT TC 
3′ and reverse, 5′ GAA GGT GAA GGT CGG AGT 3′. Data 
analysis was performed with the LightCycler 480 Software, 
release 1.5.0 SP3. Target gene expression was normalized 
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to GAPDH. All expression analyses were performed three 
times independently.
Immunofluorescence
Cells starved in serum-free (SF)-MEM (Life Technologies) 
were treated for 8, 15, and 30 min with 50 μg/ml or saturat-
ing concentration of holo-transferrin (Sigma) as previously 
described [16] and for 8 min with 20 ng/ml EGF (Sigma) 
at 37 °C and then washed twice with PBS. Cells were fixed 
with 4% paraformaldehyde/PBS for 15 min at room tem-
perature. Fixed cells were quenched for 20 min with 0.1 M 
glycine, washed with 0.2% Tween-20/PBS (PBS-T) and per-
meabilized with 0.2% Triton X-100/PBS (PBS-X) for 2 min. 
The coverslips were incubated 1 h in 5% albumin IgG free 
serum/PBS at room temperature, washed twice with PBS-T 
followed by incubation with primary antibodies (see Sup-
plementary Table 2) in 2.5% albumin IgG free/PBS, over-
night at 4 °C. After washing with PBS-T, coverslips were 
incubated with their respective secondary antibodies for 1 h 
at room temperature. Coverslips were incubated with DAPI 
(Sigma) for 3 min, and mounted with Dako Fluorescent 
mounting medium (Agilent). Slides were examined via a 
Leica SP5 fluorescence confocal microscope. Images were 
sampled at a resolution of 1024 × 1024 pixels, using a 63 × 
(NA 1.5) objective, a 5 × software zoom and a 10–15 z-step 
size of 0.2–0.3 μm. Quantification of colocalizations was 
performed using Imaris 8 (Bitplane, South Windsor, CT, 
USA), using the Imaris colocalization module. Representa-
tive histograms of overlapping fluorescence were determined 
using the Leica SP5 TCS program and expressed in arbitrary 
units (A.U.). Images were normalized to the background sig-
nal. Quantification of triple-localization was performed by 
the BlobProb plugin [17] for ImageJ [18], using a thresh-
old of ‘5’ for all three channels and counting the number 
of identified colocalized blobs after triple-staining per cell, 
analyzing three consecutive confocal stacks per image. For 
compartmental analysis, images were quantified using the 
ImageJ software. For the receptor analysis, signals were 
quantified as integrated density. For the compartment-spe-
cific analysis of the receptor, masks were obtained from the 
EEA1–, LAMP1- and RAB11-channels, corresponding to 
the endosomes, lysosomes and recycling endosomes, respec-
tively. The obtained masks were superimposed on each 
z-stack to the receptor channel, to obtain compartment-spe-
cific filtered images. Individual cells were then selected and 
circumscribed with a ROI, followed by measurement of the 
integrated density. For the endosomal count, images were 
filtered via a Gaussian blur (σ = 2), stacks were thresholded 
to binary images, overlapping particles were separated via 
watershed, and endosomes were detected using 0.3–6 μm2 
and 0.5–1 circularity.
Surface distribution, uptake, and recycling assays
Cells were grown to 80–90% confluency and starved for 1 h 
at 37 °C in SF-MEM (Invitrogen). Cells were washed once 
in ice-cold PBS, harvested, and resuspended in cold RPMI, 
supplemented with 0.2% bovine serum albumin (BSA) 
containing 25 µg/ml Alexa Fluor-647-conjugated transfer-
rin or 2.5 μg/ml Alexa Fluor-647-conjugated EGFR (both 
Thermo Fisher). Cells were incubated for 1 h on ice to stain 
the surface located receptors. Time-resolved EGFR surface 
abundance was performed by binding of EGF (20 ng/ml; 
1 h on ice) to the receptor, prior to internalization over the 
indicated time and subsequent staining of surface located 
EGFR. Receptor internalization was allowed by shifting the 
pre-stained cells to 37 °C. Fluorescence intensity of inter-
nalized TfR was determined by stopping the internalization 
after 10 and 20 min in ice-cold PBS. Fluorescence inten-
sity of internalized EGFR was determined by stopping the 
internalization after 30 min in ice-cold PBS, with or without 
pre-treating the cells for 4 h with monensin (10 μM, Sigma). 
Cells were collected and washed twice with ice-cold PBS 
and fixed in 1 mM EDTA, containing 1% glutaraldehyde/
PBS. Fluorescence signals of labeled EGF and Tf were ana-
lyzed at a FACS LSRFortessa (BD Bioscience). Unstained 
cells were used as background signal while internalized 
signal was calculated by virtual stripping of the surface sig-
nal. The TfR recycling assay was performed as previously 
described [16]. For the TfR degradation assay, cells were 
grown to 80–90% confluency and starved at 37 °C in SF-
MEM (Invitrogen). Cells were treated for 10 and 20 min 
with 50 µg/ml holo-transferrin (Sigma), with or without pre-
treatment of bafilomycin A1 (100 nM; Sigma). Total TfR 
protein was detected as previously described. All experi-
ments were performed three independent times.
Endocytic trafficking assays
pHrodo-Red-labeled Tf and pHrodo-Red-labeled EGF 
(both Thermo Fisher) were used for endocytic rate assays 
of TfR and EGFR, respectively. Briefly, cells were grown 
to 80–90% confluency and starved over night at 37 °C in 
SF-MEM. Cells were washed twice in ice-cold Live Cell 
Imaging solution (LCIS, Life Technologies) and labeled Tf 
(50 µg/ml) or labeled EGF (5 µg/ml), diluted in Live Cell 
Imaging solution (LCIS, Life Technologies), were added 
to the plate according to manufacturer’s instructions. The 
plates were transferred into the IncuCyte ZOOM platform 
inside a humidified incubator at 37 °C/5%  CO2. At least two 
images per well from at least two technical replicates were 
taken every 5–15 min over 3–4 h, using a 20 × objective. 
Images were analyzed using the IncuCyte™ Basic Software. 
Phase and red channel acquisition time was 2200 ms. In 
phase contrast, cell segmentation was achieved by applying 
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a confluence mask. An area filter was applied to exclude 
objects below 50 μm2. Red channel background noise was 
subtracted with the Top-Hat method of background; inte-
grated fluorescence signal was quantified by the software 
after applying a mask.
Cell line derived xenograft mouse model, 
immunohistochemistry and iron staining
3.0 × 106 cells of the cell lines SW480/e.v. and SW480/
MACC1, respectively, were intrasplenically transplanted into 
6–8-week-old SCID/beige mice with 10 animals per group. 
Thirty days after tumor inoculation, spleens were removed 
and shock frozen. Cryosections of the tumor loaded spleens 
were subjected to immunostaining of MACC1 (described 
in [4]) and Perl’s Prussian blue staining of intracellular iron. 
Briefly, tissue sections were allowed to thaw at room tem-
perature, were fixed with 4% formaldehyde/PBS, washed 
twice with PBS and incubated for 15 min with fresh Perl’s 
solution (5% potassium ferrocyanide, pH 1). After 3 × wash 
with PBS, slides were covered with mounting medium and 
representative pictures were taken at a 40 × magnification 
(Keyence BZ-X810). Pictures of representative cell line-
derived tumor sections stained for MACC1 were taken at a 
10 × magnification.
EGF‑mediated signaling and cell proliferation
For signaling analysis, cells were seeded in 6-well plates for 
48 h and after starvation with SF-MEM cells were stimu-
lated with 20 ng/ml EGF in RPMI (Sigma) for the indi-
cated time points. Cells lysates were subjected to WB and 
immunostaining as previously described. For determination 
of anchorage-dependent cell proliferation, cells were plated 
into 96-well plates, and grown for 72 h in the presence of 
20 ng/ml EGF (Sigma) in RPMI, supplemented with 2% 
FCS. The proliferation rate was measured via IncuCyte 
ZOOM Live-cell Analysis System (Essen BioScience). Each 
cell proliferation experiment was performed in duplicates, 
for three independent times.
In silico analysis of MACC1 and EGFR‑target genes 
in expression microarrays of CRC patients
Publicly available expression data of CRC tumor microar-
rays were obtained from the functional genomics data repos-
itory Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/geo). A total of 161 expression datasets of MACC1 and 
EGFR-target genes were normalized to G6PDH, combined 
and analyzed for direct or inverse correlation. Expression 
data of the following cohorts were used: GDS4381 [19], 
GDS4513 [20], GDS4516 [21] and GDS4718 [22].
Statistical analysis
Statistical analysis was performed using GraphPad prism 
software (v5.01, GraphPad software, La Jolla, CA, USA) 
using either unpaired two-tailed Student’s t tests, one-way 
or two-way ANOVA followed by post hoc Bonferroni cor-
rection, depending on the obtained datasets. Signal half-lives 
were calculated using the included function for nonlinear 
regression. Spearman correlation analyses were performed 
for gene expression data of patient cohorts. p values below 
0.05 were considered statistically significant.
Results
MACC1 participates in CME by interacting 
with endocytic accessory and cargo proteins
To address the functional impact of MACC1 during CME 
in CRC, we performed shotgun mass spectrometry (MS) 
analysis following a MACC1 pull-down in SW620 cells (see 
Supplementary Methods). We analyzed the MACC1-specific 
interactome in comparison with the reported cellular func-
tions of SH3BP4 and found high enrichment scores of Gene 
Ontology terms for endocytic processes, vesicle formation 
and intracellular transport (p < 0.05; Fig. 1a, Supplementary 
Table 3). We identified MACC1 interactors involved in dif-
ferent stages of vesicle formation and trafficking, e.g., adap-
tor-protein (AP) complex subunits, light and heavy chains 
of clathrin and clathrin/AP-associated proteins, dynamin 1/2 
(DNM1/2), and the CME-cargo TfR. To validate the inter-
actome screen, we performed immuno-precipitations (IP) 
of MACC1 in three CRC cell models: endogenously high 
MACC1 expressing SW620 cells and ectopic MACC1 
overexpression in endogenously low MACC1 expressing 
SW480 cells (SW480/MACC1 and SW480/MACC1-GFP). 
The interaction of MACC1 with the heavy chain 1 of clath-
rin (CLTC), dynamin 2 (DNM2) and the α-subunit of AP-2 
(AP-2α) as endocytic accessory proteins, as well as TfR was 
verified by Western blots (WB) (Fig. 1b).
The role of TfR in iron homeostasis allows for its use as a 
prognostic marker in many cancer types, including CRC [23, 
24]. Cancer cells require a high iron supply to sustain their 
proliferation and increased TfR-dependent iron uptake is 
crucial in tumorigenesis [25]. When receptor internalization 
was triggered with holo-transferrin (h-Tf), we qualitatively 
and quantitatively assessed the co-localization of MACC1 
with TfR, CLTC, DNM2 and AP-2α, confirming the involve-
ment of MACC1 in TfR endocytic trafficking in support of 
our primary observations (Fig. 2; Figure S1).
Without h-Tf, MACC1 and TfR co-localized weakly 
near the plasma membrane (PM) and in cytoplasmic vesic-
ular structures, but increased upon h-Tf mediated TfR 
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internalization (p < 0.01; Fig. 2a, Figure S1a). Similarly, we 
analyzed the co-localization of MACC1 with CLTC, DNM2, 
and AP-2α during CME. MACC1 co-localized only weakly 
with CLTC in untreated cells, but the co-localization near 
the PM and in the cytoplasmic region increased 15 min after 
h-Tf treatment (p < 0.01; Fig. 2b; Figure S1b). In contrast, 
DNM2 and MACC1 co-localized near the PM before the 
induction of CME, but showed decreased co-localization 
after h-Tf treatment (p < 0.001; Fig. 2c; Figure S1c). When 
analyzing the distribution of AP-2α and MACC1, only a 
weak co-localization near the PM was noticed before h-Tf 
treatment, which did not change after the induction of CME 
(Fig. 2d; Figure S1d). These results indicate the presence of 
MACC1 at clathrin-coated vesicles (CCV) and the associa-
tion of MACC1 to protein complexes of the ligand-stimu-
lated endocytic machinery.
We qualitatively observed a signal overlap after triple-
staining of TfR, CLTC and MACC1 in vesicular structures 
of SW480/MACC1 cells near the PM and the perinuclear 
region upon h-Tf treatment (Fig. 2e, upper row; Figure S1e). 
By triple-staining of MACC1, TfR and early endosomal 
antigen 1 (EEA1) as an endosomal marker, we observed the 
co-localization also of these proteins after h-Tf treatment 
(Fig. 2e lower row; Figure S1f). This indicates that once the 
CCV is formed and has pinched off the PM, MACC1 and 
TfR stay associated until the uncoated vesicle is fused with 
endosomes, suggesting additional functions of MACC1 in 
CME.
Differential MACC1 expression impairs the uptake 
of TfR in CRC cells
When focusing on the surface abundance of TfR observed a 
significant decrease in surface-bound Alexa 647-conjugated 
transferrin (Tf-647) in SW480/MACC1 cells, compared to 
SW480/e.v. cells (p < 0.05, Fig. 3a), while expression lev-
els of SH3BP4 and TfR were unaltered (Figure S2a, b). 
Overexpression of SH3BP4 decreased the surface signal, 
although not significantly, suggesting a similar but weaker 
role of SH3BP4 in CRC cells. We confirmed the decreased 
amount of TfR at the PM of SW480/MACC1 cells by mem-
brane fractionation and WB (Fig. 3b, upper panel). After 
15 min h-Tf treatment, we observed a decrease in TfR pro-
tein amounts at the PM for SW480/e.v. cells, while more TfR 
remained at the PM of SW480/MACC1 cells (Fig. 3b, lower 
panel). In addition, internalization of TfR/Tf-647 complexes 
over time was significantly reduced in SW480/MACC1 
cells, compared to SW480/e.v. cells (p < 0.01, Fig. 3c). To 
a lesser extent, also the overexpression of SH3BP4 reduced 
the amount of internalized TfR/Tf-647 complexes over 
time. The ‘uptake to surface’ ratio of Tf-647 was lower 
for SW480/MACC1 and SW480/SH3BP4 cells, compared 
to SW480/e.v. cells (p < 0.05 and p < 0.01, respectively; 
Fig. 3d). As surface distribution of TfR in untreated cells 
and its internalization during h-Tf treatment was decreased 
upon overexpression of MACC1 and SH3BP4 in SW480 
cells, we conclude similar cellular functions of both proteins.
We verified the role of MACC1 in TfR internalization 
in SW620 cells. The comparison of control cells (SW620/
sh control) to MACC1-silenced cells (SW620/sh MACC1) 
revealed no alteration in total TfR expression (Figure S2c, 
d), nor any change in the surface abundance of TfR, deter-
mined by Tf-647 binding and membrane fractionation (Fig-
ure S3a, b). However, we observed a significant decrease 
in Tf-647 internalization 20 min after h-Tf treatment of 
SW620/sh MACC1 cells, compared to SW620/sh control 
Endocytosis-related GO term enrichment of MACC1 interactors
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Fig. 1  MACC1 interacts with CME factors. a Interaction partners 
of MACC1 in the CRC cell line SW620 are significantly enriched 
(p < 0.05;  log2 > 0.5) for cellular processes. A list of enriched gene 
ontology (GO) terms, regarding cellular compartments, biological 
processes and molecular functions, includes vesicle formation and 
other processes of endocytosis. b Selected protein interactions of 
CME related factors with MACC1 were validated by co-IP in CRC 
cell lines with either high endogenous expression levels or ectopic 
overexpression of MACC1. COPI coat protein complex I, ER endo-
plasmic reticulum, CLTC clathrin heavy chain 1, DNM2 dynamin 2, 
AP-2α adaptor protein 2α, TfR transferrin receptor 1
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cells (p < 0.05; Figure S3c, d). These data confirm a regula-
tive role for MACC1 during TfR internalization via CME 
in CRC cells.
High MACC1 expression increases recycling 
and impairs degradation of TfR in CRC cells
Next, we followed the accumulation of TfR in acidic cel-
lular compartments, using Tf labeled with the pH-sensitive 
fluorescence dye pHrodo-Red (pH-Tf) and measured its 
pH-dependent signal intensity in real time. We observed 
significantly lower pH-Tf signal intensity in SW480/
MACC1 cells 60 min after induction of CME, when com-
pared to the control cells (p < 0.001; Fig. 3d). Similarly, 
MACC1-silencing in SW620/sh MACC1 cells increased 
the accumulation of TfR/pH-Tf complexes in acidic com-





























































































































































Fig. 2  MACC1 co-localizes with TfR and CME factors after Tf-
dependent TfR internalization. a–d Qualitative and quantitative 
assessment of co-localization of MACC1 and TfR (a), CLTC (b), 
DNM2 (c) and AP-2α d in SW480/MACC1 cells before (upper panel) 
and after 15  min (lower panel) stimulation of TfR internalization 
with h-Tf. Scale bar 10 µm. Indicated regions are displayed enlarged 
(× 10). Statistical analysis of Pearson’s correlation coefficients (n > 60 
cells analyzed, n = 3, mean ± SEM) before and after stimulation is 
performed by Student’s t tests. e, f Qualitative and quantitative assess-
ment of co-localization of MACC1, TfR and CLTC (e) or EEA1 (f) 
after triple-staining of SW480/MACC1 cells before (upper panel) 
and after 15  min (lower panel) stimulation of TfR internalization 
with h-Tf. Scale bar 10 µm. Indicated regions are displayed enlarged 
(×  10), and histograms show the spatial distribution of the signal 
intensities across indicated sections (n = 30 cells). All panels show 
merged images. Single channel images are provided in the supple-
ment. TfR transferrin receptor 1, CLTC clathrin heavy chain 1, DNM2 
dynamin 2, AP-2α adaptor protein 2α, EEA1 early endosome antigen 
1, **p < 0.01, ***p < 0.001
3532 F. Imbastari et al.
1 3
From endosomes, TfR/Tf complexes are mainly recy-
cled to the PM [26], but also regulated TfR-specific deg-
radation has been reported [27]. We assessed the recycling 
rate of TfR by measuring the loss of internalized Tf-647 
over time. Signal intensities decreased significantly faster 














































































































































































Fig. 3  Overexpression of MACC1 modulates the surface abundance 
and uptake of TfR but increases its recycling. a, b Surface staining 
of TfR of SW480-derived cell lines, with or without h-Tf treatment. 
Total surface Tf-647 signal intensities (mean ± SEM) were deter-
mined by FACS (a). PM-bound TfR was determined by WB after 
membrane fractionation of untreated cells or after 15  min of h-Tf 
(b). c Internalized Tf-647 signal intensities (mean ± SEM) after tem-
perature shift for subsequent time points and were determined by 
FACS. d Ratio of internalized to surface abundance signal intensities 
of Tf-647 (mean ± SEM). e Integrated pH-sensitive signal intensi-
ties (mean ± SEM) of internalized pH-Tf over time. f Loss of signal 
intensity (mean ± SEM) of internalized Tf-647 during h-Tf-stimu-
lated CME of TfR was analyzed using non-linear regression. g Pro-
tein level of TfR in SW480 cells with modulated MACC1 expression 
before and after stimulation of TfR internalization with h-Tf at indi-
cated time points, with β-actin as loading control. h Changes in TfR/
β-actin ratio level upon h-Tf stimulation, after quantification of WB 
signal intensities and normalization to t = 0 min. MFI mean fluores-
cence intensity, CU confluency units; all experiments were performed 
three times independently, with ANOVA as statistical analysis (except 
f: non-linear regression), *p < 0.05, **p < 0.01, ***p < 0.001
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SW480/SH3BP4 cells (p < 0.01; Fig. 3f). The signal half-
life of Tf-647 in SW480/MACC1, SW480/e.v. and SW480/
SH3BP4 cells was calculated as 5.4 min (95% CI 4.6–6.4; 
R2 = 0.95), 9.3 min (95% CI 7.8–11.4; R2 = 0.90) and 8.9 min 
(95% CI 7.1–11.9; R2 = 0.84), respectively.
By analyzing total protein content in SW480/e.v. and 
SW480/MACC1 cells, we observed increasing TfR lev-
els in SW480/MACC1 cells after h-Tf treatment (Fig. 3g). 
Normalized to untreated conditions, only SW480/e.v. cells 
showed a reduction of TfR (to about 70%) 20 min after h-Tf 
treatment (p < 0.001; Fig. 3h).
Similarly, TfR degradation in SW620/sh MACC1 cells 
was triggered upon h-Tf treatment, compared to stable TfR 
levels in SW620/sh control cells (p < 0.05; Figure S3f, g). 
In turn, TfR degradation in SW620/sh MACC1 cells was 
blocked by applying bafilomycin A1, an inhibitor of the 
vacuolar-type  H+-ATPase (Figure S3h, i).
Co-localization of TfR and Rab11 as a marker for recy-
cling endosomes and the trans-Golgi network [28] clearly 
increased 30 min after h-Tf treatment in SW480/MACC1 
cells, compared to SW480/e.v. cells (p < 0.001; Fig. 4a, 
c; Figure S4a). In contrast, co-localization of internalized 
TfR and the lysosomal-associated membrane glycopro-
tein 1 (LAMP1) in SW480/MACC1 cells decreased after 
h-Tf treatment, compared to SW480/e.v. cells (Fig. 4b, c; 
Figure S4b). The compartmental count showed increased 
endosomal structures in SW480/MACC1cells compared to 
control cells, supporting our previous observations (p < 0.05 
Fig. 4d).
To assess, if the MACC1-dependent stabilization of TfR 
and its faster recycling leads to alterations of iron homeo-
stasis, we stained tissue sections of cell line-derived tumor 
sections with Perls’ Prussian blue solution. Tumors derived 
from SW480/MACC1 cells showed substantially stronger 
signals when stained for MACC1, compared to tumors 
derived from SW480/e.v. (Fig. 4e). The higher MACC1 
expression levels in the SW480/MACC1-derived tumor tis-
sue are also associated with a stronger iron staining, com-
pared to SW480/e.v.-derived tumors (Fig. 4e).
Thus, we conclude that elevated MACC1 expression in 
CRC cells caused decreased localization of internalized TfR 
into acidic cellular compartments, resulting in decreased 
receptor degradation, while reduced MACC1 expression 
increased its degradation. MACC1 overexpression increased 
the localization of TfR into recycling endosomes, which 
favors its recycling.
Critical domains of MACC1 in TfR endocytosis
MACC1 harbors predicted interaction sites for CME-
related proteins  [9]. To evaluate their importance in 
the MACC1-dependent alteration of the TfR cycle, we 
deleted the N-terminal CME-related interaction motifs 
(ΔNT), the SH3-domain (ΔSH3), and a combination of 
both (ΔNTΔSH3) (Fig. 5a). We thus generated the cell 
lines SW480/MACC1ΔNT-GFP, SW480/MACC1ΔSH3-
GFP and SW480/MACC1ΔNTΔSH3-GFP, respectively, 
with SW480/MACC1-GFP as a control. We observed 
a re-localization of ΔSH3-MACC1 variants from the 
PM toward the cytoplasm, compared to full-length (fl-) 
MACC1 (Figure S5a). This suggests a stronger role of the 
SH3-domain in the MACC1-dependent effects of the TfR 
cycle compared to the N-terminal interaction motifs. Strik-
ingly, the interaction of fl-MACC1 with CLTC and DNM2 
was lost in any of the generated deletion variants (Fig. 5b, 
c), although their expression was similar to fl-MACC1 
(Figure S2e, f). When we challenged the interaction of 
MACC1 deletion variants and TfR, protein binding still 
occurred in the ΔNT-MACC1 variant, but was lost upon 
deleting the SH3-domain (Fig. 5d). This result points to a 
MACC1/TfR core complex, mediated by the SH3-domain 
of MACC1, which can be linked to CME complexes via 
the N-terminal interaction motifs.
SW480/MACC1ΔNT-GFP cells showed a simi-
lar surface abundance of TfR, compared to SW480/
MACC1-GFP cells. In contrast, MACC1ΔSH3-GFP and 
MACC1ΔNTΔSH3-GFP cells accumulated TfR at the cell 
surface (p < 0.05; Fig. 5e). Intriguingly, the uptake of TfR/
Tf-647 complexes 20 min after Tf-647 treatment is pro-
gressively decreasing with the deletion of the interaction 
motifs, compared to fl-MACC1 (Fig. 5f).
We confirmed the impaired uptake and localization 
into early endosomal compartments of Tf-647 in SW480/
MACC1-GFP and SW480/MACC1ΔSH3-GFP cells by 
confocal microscopy. We found reduced levels of inter-
nalized Tf-647 in SW480/MACC1ΔSH3-GFP cells, com-
pared to SW480/MACC1-GFP cells (p < 0.001; Fig. 5g, 
h; Figure S4c), while compartment-specific quantifica-
tion of early endosomal structures showed no alterations 
in SW480/MACC1ΔSH3-GFP cells, compared to SW480/
MACC1-GFP cells, confirming our data.
The accumulation of TfR in late endocytic compart-
ments is decreased in cells expressing high levels of 
MACC1 (as shown in Figs. 3d, S3d) and this finding is 
also valid for GFP-tagged full-length MACC1. Sequential 
deletion of interaction sites in MACC1 also impairs the 
pH-Tf signal intensity (p < 0.001; Fig. 5i).
The deletion of the N-terminal interaction motifs of 
MACC1 resulted in the loss of the interaction with CLTC 
and DNM2. Only the deletion of the SH3-domain of 
MACC1 strongly impaired the interaction with TfR, its 
internalization and endosomal localization.
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MACC1 expression promotes CME‑dependent EGFR 
recycling
CME-mediated internalization and recycling of PM proteins 
can contribute to cancer progression by increasing signaling 
pathway intensities or altering cell adhesion [29]. With the 
observed role of MACC1 in the balance of TfR recycling 
and degradation, we analyzed its impact on CME-regulated 
internalization, recycling or degradation of other cancer-
related signaling receptors.
In CRC, upregulated EGFR signaling correlates with 
higher cell proliferation and leads to increased cell motil-
ity and survival  [30]. Triggering EGFR kinase activity 
increases not only the surface abundance of TfR but also 
its co-localization in vesicles [31]. After triple-staining of 
EGFR, TfR and CLTC upon EGF treatment (8 min, 20 ng/
ml) [32] TfR and EGFR did co-localize only weakly at the 
PM or in vesicles of SW480/e.v. cells (Fig. 6a; Figure S5b). 
In contrast, SW480/MACC1 cells showed more and larger 
areas of receptor co-localization after EGF treatment, also 
in combination with clathrin. When quantified, we found 
an almost six-fold increase in the co-localization of EGFR, 
TfR and CLTC in SW480/MACC1 cells, compared to 
SW480/e.v. cells (Fig. 6b). These findings confirm that TfR 
and EGFR follow the same early steps of CME in CRC cells 
and that high MACC1 levels increase the EGFR load in TfR-
containing vesicles.
With EGFR and TfR sharing the same compartments, 
we hypothesized also an effect of MACC1 on the endo-
cytic fate of EGFR. After ligand-stimulated CME EGFR 
is sorted within 30 min to either recycling endosomes or 
is targeted for degradation in lysosomes [32]. MACC1 is 
also present in EGFR-containing protein complexes, shown 
by co-precipitation of MACC1 after pulling-down EGFR in 
both SW620 and SW480/MACC1 cells (Fig. 6c). We then 
followed the EGFR-mediated internalization and accumula-
tion of pHrodo-Red labeled EGF (pH-EGF) in acidic cellular 
compartments under differential MACC1 expression.
At low ligand concentrations, EGFR progresses further 
to recycling compartments. When the surrounding pH is 
decreasing, EGF is released and accumulates [33, 34]. At 
high ligand concentrations, EGFR internalization leads to 
lysosomal sorting and subsequent receptor degradation [32].
Treatment of SW480/MACC1-GFP cells with high con-
centrations of EGF (5 µg/ml) resulted in increased signal 
intensity over time, compared to SW480/GFP cells (Fig. 6d). 
When pre-treated with dynasore, a specific inhibitor of the 
dynamin GTPase activity, both cell lines showed equally 
low signals, confirming a dynamin-dependent internalization 
of the receptor. The increased accumulation of pH-EGF in 
acidic compartments upon MACC1 overexpression and high 
pH–EGF concentrations suggests a role for MACC1 also in 
the fate decision of internalized EGFR, although this effect 
might be masked by the activation of NCE [32].
When we analyzed the surface abundance of EGFR 
over time after inducing CME-driven receptor internaliza-
tion with low concentrations of EGF (20 ng/ml) [32, 35] 
we observed a strong decrease of PM-bound EGF-647 in 
both cell lines within 10 min, but a significant increase of 
PM-bound EGF-647 in SW480/MACC1 cells from 30 min 
on (p < 0.001; Fig. 6e) while pre-treatment with dynasore 
inhibited CME-based receptor internalization. We validated 
this finding in an additional CRC cell panel with different 
MACC1 expression. EGF-treatment of HCT116 cells with 
ectopic expression of MACC1-GFP resulted in higher sig-
nal intensity after surface staining with EGF-647, com-
pared to GFP-expressing control cells (p < 0.01; Fig. 6f). 
Additional treatment with monensin, an inhibitor of endo-
cytic recycling [36], showed a decrease in signal activity 
only in HCT116/MACC1-GFP cells, but not in the control 
cells (p < 0.01; Fig. 6g). To better understand the fate of 
EGFR, we stimulated SW480/MACC1-GFP and SW480/
MACC1ΔSH3-GFP cells with EGF-647 for 30 min and indi-
rectly followed the routing of the EGFR/EGF-647 complex 
into endocytic compartments. EGF-647 was found equally 
co-localizing with EEA1-marked endosomal compart-
ments in both cell lines (Figure S6a). Compartment-spe-
cific quantification showed no difference in the counts of 
EEA1-marked endosomal compartments (Figure S6d), as 
well as the integrated EGF-647 density in EEA1-marked 
compartments (Figure S6e). Similarly, no alterations in 
LAMP1-marked degradative compartments were observed 
(Figure S6b, d), but we recorded increased EGF-647 den-
sity in these compartments of SW480/MACC1ΔSH3-GFP 
cells, compared to SW480/MACC1-GFP (Figure S6b, e). In 
addition, although we observed no difference in the counts 
of Rab11-marked recycling compartments (Figure S6c, d), 
we recorded increased EGF-647 density in these compart-
ments of SW480/MACC1-GFP cells, compared to SW480/ 
MACC1ΔSH3-GFP cells (Figure S6c, e). Taken together, 
this data set strongly confirms our initial hypothesis of 
Fig. 4  Overexpression of MACC1 localizes TfR to recycling 
endosomes. a, b Co-localization of TfR and Rab11 (a) or LAMP1 
(b) in SW480 cells with modulated MACC1 expression after h-Tf 
stimulated TfR internalization. c Statistical analysis of Person’s cor-
relation coefficients (n = 10 cells; mean ± SEM, n = 3) before and after 
h-Tf treatment are performed by Student’s t test. d Endosomal count 
and integration of endosome-specific Tf-647 intensity in SW480/
MACC1 and SW480/e.v. cells (n = 20 cells; mean ± SEM). Statistical 
analysis was performed by Student’s t test. e Tumor sections of cell 
line-derived xenograft mouse models after intrasplenical transplanta-
tion. Sections of tumors derived from SW480/e.v. cells and SW480/
MACC1 cells were analyzed for MACC1 expression by immunohis-
tochemistry, and in parallel stained for intracellular iron. Scale bar 
10  µm. Indicated regions are displayed enlarged (×  10). All panels 
show merged images. Single channel images are provided in the sup-
plement. Rab11 Ras-related protein Rab11, LAMP1 lysosomal associ-
ated membrane protein 1; **p < 0.01, ***p < 0.001
◂
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MACC1 as a factor to indirectly enhance the routing of the 
EGFR/EGF-647 complex into recycling compartments, 
rather than into degradative compartments. Impairing 
MACC1 by deleting its SH3 domain results in enhanced 
routing of the EGFR/EGF-647 complex into degradative 
compartments.
Thus, the MACC1-mediated increase in TfR recycling 
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recycled receptors at the PM for further rounds of internali-
zation in MACC1-high expressing CRC cells.
MACC1 expression promotes stronger and sustained 
EGFR signaling
Increased recycling of activated receptors, combined with 
reduced degradation, leads to stronger or sustained down-
stream activity of the affected signaling pathways  [10]. 
Dependent on the MACC1-promoted increase of EGFR 
recycling at low EGF concentrations (Fig. 6e–g), we ana-
lyzed the activation of EGFR, its internalization and its 
effect on downstream signaling.
We observed no change in the surface abundance of 
EGFR of SW480/MACC1ΔNT-GFP cells in compari-
son with SW480/MACC1-GFP cells (Fig. 7a). Similarly 
to the increased surface abundance of TfR (see Fig. 5d), 
we observed a significant increase in EGF-647 signal 
intensity of SW480/MACC1ΔSH3-GFP and SW480/
MACC1ΔNTΔSH3-GFP cells (p < 0.05; Fig. 7a). This sug-
gests also similar interference with receptor internalization 
as seen for TfR (Fig. 5e). This signal increase was not related 
to EGFR expression in the cell lines (Figure S2g, h).
In addition, we observed altered downstream signaling 
activity of stimulated EGFR (20 ng/ml EGF) by probing 
the phosphorylation status of the receptor and downstream 
signaling factors. EGFR (pY1068)-phosphorylation was 
peaking 30 min after EGF treatment in SW480/GFP cells 
(Fig. 7b, left panel). In contrast, we observed an earlier 
and stronger onset of maximal EGFR-phosphorylation in 
SW480/MACC1-GFP cells, shown by significantly higher 
signal intensities after stimulation (p < 0.01; Fig.  7c). 
Moreover, we observed a more than threefold increase in 
EGFR-phosphorylation after 8 min in SW480/MACC1-
GFP cells, compared to SW480/GFP cells (p < 0.01; 
Fig. 7c). By looking at downstream signaling events, we 
found significantly stronger Erk1/2-phosphorylation in 
SW480/MACC1-GFP cells after 8 and 30 min of EGF 
treatment, compared to untreated cells, which was only 
seen to a lesser extent in SW480/GFP cells (Fig. 7d).
Cell lines expressing the MACC1 deletion variants 
showed intermediate EGFR-phosphorylation, indicat-
ing that the deletions inhibit, but does not abrogate the 
enhancing effect of MACC1 (Fig. 7c). While SW480/
MACC1ΔNT-GFP cells show a significant increase of 
Erk1/2-phosphorylation after 8 and 30 min of EGF treat-
ment compared to untreated cells (p > 0.05, Fig. 7d), this 
effect was lost when the SH3-domain of MACC1 was 
deleted.
The different pattern of EGFR activation in the panel of 
SW480 cells expressing MACC1 deletion variants is also 
seen in EGF-dependent cell proliferation. The expression 
of fl-MACC1-GFP significantly increased the proliferation 
rate (p < 0.01; Fig. 7e), compared to GFP expression alone. 
SW480/MACC1ΔNT-GFP cells grew similar to MACC1-
GFP expressing cells, whereas the loss of the SH3-domain 
in MACC1 returns cell proliferation to the rate of SW480/
GFP cells.
Taken together, overexpression of MACC1 results in 
earlier onset and higher intensity of EGFR-phosphoryl-
ation, leading to intensified downstream signaling via 
MAPK/Erk. This contributes to increased proliferation 
of CRC cells. The loss of N-terminal interaction motifs 
of MACC1 delays EGFR-phosphorylation and shortens 
Erk1/2. However, the deletion of the SH3-domain of 
MACC1 reduces its phosphorylation state and thus down-
stream MAPK/Erk signaling.
MACC1 correlates with EGFR‑target genes in CRC 
patient cohorts
Besides activating downstream signaling pathways upon 
ligand binding, EGFR also contributes to the expression 
for various oncogenes when internalized by CME [37]. 
As a transcriptional co-activator it regulates the expres-
sion of several target genes: cyclin D1 (CCND1), induc-
ible nitric oxide synthase (NOS2), Myb-related protein B 
(MYBL2), Aurora Kinase A (AURKA), cyclooxygenase-2 
(COX-2), Myc proto-oncogene protein (MYC), and breast 
cancer resistant protein (BCRP) (reviewed in [38]). We 
analyzed four publicly available expression microarray 
datasets from different CRC patient cohorts and observed 
a significant and positive correlation with five of the seven 
reported EGFR-target genes (Table 1, Figure S7).
Fig. 5  Deletion of protein interaction sites in MACC1 impacts CME-
factor binding, TfR internalization and recycling. a Schematic view 
of MACC1 variants with deleted N-terminal CME-related interac-
tion motifs (MACC1ΔNT, top), deleted SH3-domain (MACC1ΔSH3, 
middle), and a combination of both deletions (MACC1ΔNTΔSH3, 
bottom), C-terminally tagged with GFP. b–d Pull-down of MACC1 
deletion variants and immunostaining for CLTC (b), DNM2 (c) or 
TfR (d). e Surface staining of TfR with Tf-647 of SW480-derived 
cell lines. Total surface Tf-647 signal intensities (mean ± SEM) 
were determined by FACS. f Internalized Tf-647 signal intensities 
(mean ± SEM) after temperature shift to 37  °C for 20  min. g Inter-
nalization of TfR/Tf-647 and co-staining of EEA1 in SW480 cells 
expressing GFP-tagged full length MACC1, or the SH3-domain dele-
tion variant, after Tf-647-dependent TfR internalization. h Quantifi-
cation and integration of Tf-647 intensity of SW480/MACC1-GFP 
and SW480/MACC1ΔSH3-GFP in EEA1-marked endosomal com-
partments. Statistical analysis of integrated Tf-647 signal densities 
(n = 10 cells; mean ± SEM) was performed by Student’s t test. i Inte-
grated pH-sensitive signal intensities (mean ± SEM) of internalized 
pH-Tf over time. MFI – mean fluorescence intensity; EEA1 early 
endosome antigen 1, CU confluency units; all experiments were per-
formed three times independently, with ANOVA as statistical analysis 
(except d: Student’s t test), *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 6  MACC1 facilitates EGFR internalization and recycling. a 
Co-localization of TfR, CLTC and EGFR after triple-staining and 
8  min treatment with 20  ng/ml EGF, in SW480/e.v. and SW480/
MACC1 cells. Scale bar 10  µm. Indicated regions are displayed 
enlarged (× 10), and histograms show the spatial distribution of the 
signal intensities across indicated sections (n = 30 cells). All pan-
els show merged images. Single channel images are provided in the 
supplement. b Quantification of co-localization areas of TfR, CTLC 
and EGFR (n = 8; 3 confocal layers each), with statistical analysis by 
Student’s t test. c Co-IP of MACC1 and immunostaining for EGFR. 
d Integrated pH-sensitive signal intensities (mean ± SEM) of inter-
nalized pH-EGF over time. e Surface signal of EGF-647 in SW480/
MACC1 and SW480/e.v. cells over time. CME of EGFR was stimu-
lated with pre-bound EGF and blocked with dynasore. f, g Surface 
signal of EGF-647 in HCT116 cells with modulated MACC1 expres-
sion, before and after 30  min of EGF-stimulated EGFR internaliza-
tion (f) or with parallel blocking of endosome acidification by mon-
ensin (g). TfR transferrin receptor 1, CLTC clathrin heavy chain 1, 
EGF/R epidermal growth factor/receptor, CU confluency units, MFI 
mean fluorescence intensity; all experiments were performed three 
times independently, with ANOVA as statistical analysis (except B: 
Student’s t test), *p < 0.05, **p < 0.01, ***p < 0.001
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Discussion
Here we report, that MACC1, a causal and prognostic 
marker for CRC metastasis, is involved in the regulation 
of cancer-related growth factor signaling (Figure S8). By 
evaluating the interactome of MACC1, we found a con-
siderable overlap in endocytosis-related GO terms to the 
reported function of the highly similar protein SH3BP4. 
Colocalization and interaction of MACC1 with the CME 
cargos TfR and EGFR affects their endocytic cycle by 
increasing receptor recycling. The increase of TfR recycling 
and its decreased degradation resulted in an accumulation 
of iron in MACC1 overexpressing cells. Similarly, increased 
EGFR recycling resulted in enhanced EGFR-activation and 
downstream signaling upon MACC1 expression, leading to 
increased proliferation of CRC cells.
When we validated MACC1 binding to central endocytic 
factors, like adaptor–protein complex, clathrin and dynamin 
we found the predicted linear interaction motifs (NPF, DPF) 
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Fig. 7  MACC1 overexpression leads to earlier and stronger EGFR 
Y1068-phosphorylation. a Surface staining of EGFR with EGF-647. 
Total surface EGF-647 signal intensities (mean ± SEM) were deter-
mined by FACS. b Protein levels of EGFR, Erk1/2, and their respec-
tive phosphorylated versions, after treatment with 20  ng/ml EGF 
for the indicated time points, were detected by WB with β-actin as 
loading control. c, d Densitometry of target specific WB staining as 
the ratio of phosphorylated to non-phosphorylated EGFR (c) and the 
downstream signaling proteins Erk1/2 (d). e Proliferation of SW480-
derived cell lines was induced with 20 ng/ml EGF and monitored as 
confluency (mean ± SEM) over 72  h. MFI mean fluorescence inten-
sity, EGF/R epidermal growth factor/receptor, Erk1/2 extracellular 
signal-regulated kinase 1/2; all experiments were performed three 
times independently, with ANOVA as statistical analysis, *p < 0.05, 
**p < 0.01
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contains an SH3-domain, able to bind proline-rich domains 
(PRD) of interaction partners  [39]. The deletion of this 
domain disrupted the interaction of MACC1 also with TfR. 
This type of interaction is common for recruitment and 
modulation of the endocytosis machinery in CCV forma-
tion [40]. Additionally, although MACC1 might not directly 
interact with TfR at its intracellular tail, MACC1 stays asso-
ciated with TfR when it has reached early endosomal com-
partments, as shown by co-localization.
The ability of MACC1 to interact with CME-associated 
factors implies a MACC1-dependent modulation of one or 
several steps of CME. Focusing on receptor internaliza-
tion, trafficking, degradation and recycling we employed 
TfR as a model system for analyzing each process. Both 
overexpression and knock-down of MACC1 affected the 
CME-dependent receptor internalization. Similar effects 
have been reported for the homologous protein SH3BP4, 
where TfR uptake was also impaired by the perturbation of 
SH3BP4 expression levels [8]. As MACC1 is virtually not 
expressed in SW480 cells, we would not consider MACC1 
as a constant component of the endocytosis machin-
ery [41], but its overexpression might interfere with CME-
dependent receptor internalization due to competing pro-
tein interactions, as it has been suggested for SH3BP4 [8]. 
More importantly, we found a role of MACC1 in later 
steps of CME, when the cargo is targeted either for lyso-
somal degradation or recycling [26, 27]. MACC1 overex-
pression decreased the co-localization of TfR and LAMP1, 
and substantially increased the co-localization of TfR with 
Rab11, markers for lysosomes or recycling endosomes, 
respectively [42, 43]. A possible mechanism for the faster 
signal decrease of internalized Tf-bound fluorescence in 
MACC1 overexpressing cells and the reduced accumula-
tion of Tf-647 in late endosomes is a switch from slow 
TfR recycling by the perinuclear or endocytic recycling 
compartments to rapid recycling of TfR directly by the 
sorting endosomes [44, 45]. On the other hand, we observe 
stabilized amounts of total TfR after CME stimulation in 
high MACC1 expressing cells. Still, it needs to be clarified 
whether the degradation of TfR is actively blocked, or if 
this effect is caused by re-routing of the entire TfR pool 
towards recycling.
Previous reports show a correlation between the inter-
nalization of activated EGFR and TfR [31]. We also observe 
a stronger co-localization of both receptors after EGF-
treatment, indicating that TfR and EGFR share the same 
early steps of CME in CRC cells. The binding of MACC1 
to TfR and EGFR, and the presence of both receptors in 
CCVs after the induction of CME indicates that MACC1 
plays a role in the fate of EGFR. This was validated by 
increased recycling rates of EGFR, and a reversed effect by 
applying the protein transport inhibitor monensin [36]. To 
verify receptor internalization by CME we stimulated cells 
with low concentrations of EGF, which is known to cause a 
higher degree of subsequent receptor recycling, compared 
to degradation [32].
The decision for recycling over degradation is made for 
EFGR by the pathway of receptor internalization, depend-
ing on the ligand concentration  [32]. Possible explana-
tions for this phenomenon have already been suggested by 
Peschard et al. [46], who report a lower internalization rate 
and increased recycling of heterodimers of EGFR and other 
ErbB family members, like HER2. This is also highly likely 
in our cells, as elevated HER2 expression has frequently 
been described in CRC and confers resistance to EGFR-
based therapy [47–49].
We have reported here that full-length MACC1 has an 
enhancing effect on EGFR-phosphorylation at Y1068. This 
creates an interaction site for Grb2 [50] and leads to subse-
quent activation of the MAPK/Erk signaling cascade. The 
downstream signaling cascades of EGFR, their critical pro-
tein interaction partners and cancer promoting effects have 
recently been reviewed [51, 52]. Although the MACC1-
induced proliferation of CRC cells can now be linked to 
enhanced TfR and EGFR recycling, more cancer-related 
RTKs and respective downstream signaling pathways may 
Table 1  Correlation of MACC1 expression with EGFR-target genes in combined CRC microarray datasets
CCND1 cyclin D1, NOS2 inducible nitric oxide synthase, MYBL2 Myb-related protein B, AURKA aurora kinase A, COX-2 cyclooxygenase-2, 
MYC Myc proto-oncogene protein, BRCP breast cancer resistant protein
EGFR-target gene CCND1 NOS2 MYBL2 AURKA COX-2 MYC BCRP
Spearman r 0.7739 0.7611 0.8325 0.8081 − 0.09448 0.8636 0.1076
95% Confidence interval 0.7011–0.8307 0.6848–0.8208 0.7762–0.8757 0.7447–0.8570 − 0.2499 to 0.06572 0.8167–0.8992 − 0.05254 
to 
0.2623
p value < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.2332 < 0.0001 0.1744
p (two-tailed) **** **** **** **** ns **** ns
Significant? 
(alpha = 0.05)
Yes Yes Yes Yes No Yes No
Number of pairs 161 161 161 161 161 161 161
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be affected by this mechanism and should be the focus of 
future studies.
However, the intensity and duration of downstream 
signaling is decreased when protein interactions between 
MACC1 and CME-related factors are disrupted. These 
interaction sites have been shown to be critical for EGF-
induced cell proliferation. Nevertheless, the alterations in 
protein complexes during CME in the presence or absence of 
MACC1 still need to be investigated in more detail. Potential 
interaction inhibitors of MACC1 and CME factors, like pep-
tides or peptidomimetic compounds, can then be evaluated 
for clinical use.
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